Clinical Trial Update: Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the safety and efficacy of ABP-745 in participants with an acute gout flare. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Gouty Arthritis

Drugs mentioned

• ABP-745

Snippet

Sponsor: Atom Therapeutics Co., Ltd | Conditions: Acute Gouty Arthritis, Gout Flare | Phase 2 | Status: RECRUITING